Silvana Leo
Impact in
- Oncology top 10%
- Colorectal Cancer Treatments and Studies
- Cancer Treatment and Pharmacology
- Lung Cancer Research Studies
- Hepatology top 10%
- Hepatocellular Carcinoma Treatment and Prognosis
Papers in
- Oncology 14
- Colorectal Cancer Treatments and Studies 11
- Cancer Treatment and Pharmacology 6
- Lung Cancer Research Studies 3
-
- Gastric Cancer Management and Outcomes 6
- Co-authors
- Giovanni Misciagna (2 shared papers)Salvatore Tafuto (6 shared papers)A. Farris (6 shared papers)Vito Lorusso (5 shared papers)Luigi Maiorino (6 shared papers)B. Massidda (6 shared papers)Rossana Casaretti (4 shared papers)D. Natale (5 shared papers)
- Journals
- Cancer (3 papers)Annals of Oncology (2 papers)BMJ Open (1 paper)Oncotarget (1 paper)Diseases of the Colon & Rectum (1 paper)
- Partner nations
- ItalyUnited KingdomUnited States
In The Last Decade
Silvana Leo
17 papers receiving 345 citations
Peers
Comparison fields: 5 of 41
- Oncology 250
- Hepatology 63
- Neurology 54
- Epidemiology 118
- Dermatology 25
Countries citing papers authored by Silvana Leo
This map shows the geographic impact of Silvana Leo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Silvana Leo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Silvana Leo more than expected).
Fields of papers citing papers by Silvana Leo
This network shows the impact of papers produced by Silvana Leo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Silvana Leo. The network helps show where Silvana Leo may publish in the future.
Co-authors
The 25 scholars most cited alongside Silvana Leo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2005 | 69 | |
| 2 | 1990 | 48 | |
| 3 | 2005 | 38 | |
| 4 | 1989 | 35 | |
| 5 | 2015 | 25 | |
| 6 | 2019 | 24 | |
| 7 | 2000 | 23 | |
| 8 | 1994 | 18 | |
| 9 | 2020 | 16 | |
| 10 | Cigarette smoking and ulcerative colitis. A case control study. | 1989 | 14 |
| 11 | 2009 | 13 | |
| 12 | 5-fluorouracil and levofolinic acid with or without recombinant interferon-2b in patients with advanced colorectal carcinoma: a randomized multicenter study with stratification for tumor burden and liver involvement by the Southern Italy Oncology Group. | 1999 | 11 |
| 13 | 2004 | 9 | |
| 14 | 1999 | 5 | |
| 15 | 2005 | 5 | |
| 16 | 2007 | 3 | |
| 17 | 1999 | 2 |
About Silvana Leo
Silvana Leo is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Hepatology, Epidemiology and Neurology, having authored 17 papers that have together received 358 indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (11 papers), Hepatocellular Carcinoma Treatment and Prognosis (6 papers), Cancer Treatment and Pharmacology (6 papers), Gastric Cancer Management and Outcomes (6 papers), Neuroendocrine Tumor Research Advances (3 papers), Lung Cancer Research Studies (3 papers), Neuroblastoma Research and Treatments (3 papers) and Inflammatory Bowel Disease (2 papers). The work is most often cited by research in Oncology (250 citations), Hepatology (63 citations), Neurology (54 citations), Epidemiology (118 citations) and Dermatology (25 citations). Silvana Leo has collaborated with scholars based in Italy, United Kingdom and United States. Frequent co-authors include Giovanni Misciagna, Salvatore Tafuto, A. Farris, Vito Lorusso, Luigi Maiorino, B. Massidda, Rossana Casaretti, D. Natale, Pasquale Comella and Michele Cannone. Their work appears in journals such as Cancer, Annals of Oncology, BMJ Open, Oncotarget and Diseases of the Colon & Rectum.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.